Skip to main content
Premium Trial:

Request an Annual Quote

UT Molecular Medical Center Taps GenoLogics for Translational Research Software

NEW YORK (GenomeWeb News) – A University of Texas medical research center will collaborate with GenoLogics to develop an integrated software solution for use in its translational medical bioinformatics research programs, GenoLogics said today.
The Vancouver, British Columbia-based company said it will work with the Sealy Center for Molecular Medicine at the University of Texas Medical Branch at Galveston to develop biospecimen-management software.
The SCMM, which is part of the Institute for Translational Sciences, is focused on developing new tools for studying biomarkers and human diseases at the molecular level.
“In order to validate our biomarkers for common diseases, we needed to exchange information from clinical to research domains,” SCMM’s director of Biomarker Discovery, Kevin Rosenblatt, said in a statement. 
To do that, Rosenblatt said, SMCC sought “a biomedical informatics solution that not only tracks our biospecimens, but also the clinical annotations and then connects to the data being generated in our research labs.”
The system that the company and the center develop will “bring it all together in a single platform,” he added.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.